BPH - Benign Prostatic Enlargement

REVIEW UroToday

NOSTRIN is involved in benign prostatic hyperplasia via inhibition of proliferation, oxidative stress, and inflammation in prostate epithelial cells. October 24, 2024

Short-term postoperative recovery for patients after Thulium Laser Vapoenucleation of Prostate: evaluation of the impact of lower urinary tract symptoms on quality of life. October 24, 2024

Dutasteride, a 5 alpha reductase inhibitor, could be associated with the exacerbation of inflammation in patients with benign prostatic hyperplasia. October 24, 2024

Comparative Analysis of Holmium Laser Enucleation of the Prostate (HoLEP) and Robotic Assisted Simple Prostatectomy (RASP) in BPH Management: A Systematic Review and Meta-Analysis. October 21, 2024

Teverelix is a potential treatment option for the prevention of acute urinary retention recurrence in men suffering from benign prostatic hyperplasia. October 21, 2024

Evaluation of Peri-Operative Outcomes after Prostatic Urethral Lift with Emphasis on Urodynamic Changes, Symptom Improvement and Sexual Function. October 18, 2024

Second-generation MOSES 2.0 versus MOSES 1.0 pulse-modulation technologies for holmium laser enucleation of the prostate (HoLEP). October 18, 2024

Predictors of symptomatic relief in water vapor thermal therapy for prostatic hyperplasia: 36-month prospective study. October 18, 2024

Testosterone and 5 Alpha Reductase Inhibitor (5ARI) in Benign Prostatic Hyperplasia (BPH): A historical perspective October 17, 2024

Artificial Urinary Sphincter Implants in Men: a National Healthcare Data System-based Study to Assess Reinterventions in France. October 17, 2024

Ejaculation preserving TURP (Ep-TURP): A viable alternative in sexually active males with BOO-a single centre prospective randomized study. October 14, 2024

Association between circulating inflammatory proteins and benign prostatic disease: a Mendelian randomization study. October 14, 2024

A systematic review of robot-assisted simple prostatectomy outcomes by prostate volume. October 13, 2024

Recent Advancements in Prostate Catheters and Stents for Management of Benign Prostatic Hyperplasia. October 13, 2024

Evaluating the efficacy and safety of Holmium laser enucleation of the prostate in patients with obstructive uropathy attributable to bladder outlet obstruction. October 13, 2024

Prospective observational study on the efficacy and tolerability of a complex of phytochemicals versus dutasteride in the treatment of Lower Urinary Tract Symptomps due to Benign Prostatic Hyperplasia. October 7, 2024

Association Between Alpha-1 Adrenoreceptor Antagonist Use and Cognitive Impairment: A Systematic Review. October 6, 2024

Downregulation of PIEZO2 in the Detrusor of Men With Bladder Outlet Obstruction and Its Association With Urinary Retention and Decreased Bladder Compliance. October 6, 2024

A genetic study to identify pathogenic mechanisms and drug targets for benign prostatic hyperplasia: a multi-omics Mendelian randomization study. October 6, 2024

Predictors of achieving a minimal clinically important difference in lower urinary tract symptoms 3 months after Rezum therapy. September 30, 2024

Page 1 of 140